Diabetes, type 1 diabetes, young-onset, children and young adults, non-autoimmune diabetes, sub-Saharan Africa
adult type 1 diabetes, type 1 diabetes screening, T1DGRS, genetic predisposition, early stage type 1 diabetes, presymptomatic type 1 diabetes
SARS-CoV-2, immune-mediated inflammatory diseases, inflammatory bowel disease, thiopurine, azathioprine, anti-TNF therapy, infliximab, vedolizumab, immunosuppressant, vaccine, ChAdOx1 nCoV-19, BNT162b2, mRNA1273, breakthrough infection, Omicron, BA.4/5